Hannah Wingate, Ph.D.
Assistant Professor in Biology
Education
-
BS in Biology, University of New Mexico
-
MS in Immunology, University of Texas-Houston Health Science Center
-
PhD in Cancer Biology, University of Texas-Houston Health Science Center
Courses Taught
-
Introductory Biology
-
General Biology I
-
General Biology II
-
Advanced Cell Biology
-
Molecular Biology
-
Tissue Culture Techniques
-
Senior Seminar
Teaching Focus
Dr. Wingate’s teaching focus is on introducing non-majors to the field of biology and developing critical thinking and laboratory skills in the upper-level courses.
Publications
Dr. Wingate’s collaboration with scientists in the Texas Medical Center has resulted in several publications:
-
Targeting low molecular weight cyclin E (LMW-E) in breast cancer. Nanos-Webb A, Jabbour NA, Multani AS, Wingate H, Oumata N, Galons H, Joseph B, Meijer L, Hunt KK, Keyomarsi K. Breast Cancer Res Treat. 2011 Jun 22.
-
MDA-7 results in downregulation of AKT concomitant with apoptosis and cell cycle arrest in breast cancer cells. Valero V 3rd, Wingate H, Chada S, Liu Y, Palalon F, Mills G, Keyomarsi K, Hunt KK. Cancer Gene Ther. 2011 Jul;18(7):510-9. doi: 10.1038/cgt.2011.20.
-
Absence of pRb facilitates E2F1-induced apoptosis in breast cancer cells. Sun B, Wingate H, Swisher SG, Keyomarsi K, Hunt KK. Cell Cycle. 2010 Mar 15;9(6):1122-30.
-
Low-molecular-weight cyclin E can bypass letrozole-induced G1 arrest in human breast cancer cells and tumors. Akli S, Bui T, Wingate H, Biernacka A, Moulder S, Tucker SL, Hunt KK, Keyomarsi K. Clin Cancer Res. 2010 Feb 15;16(4):1179-90.
-
Low molecular weight cyclin E is specific in breast cancer and is associated with mechanisms of tumor progression. Wingate H, Puskas A, Duong M, Bui T, Richardson D, Liu Y, Tucker SL, Van Pelt C, Meijer L, Hunt K, Keyomarsi K. Cell Cycle. 2009 Apr 1;8(7):1062-8.
Additional Information
Dr. Wingate is a co-sponsor of the Iota Omicron chapter of TriBeta Biologic Honor Society at HBU.